Back to search

Poland· PL-100048720

Hipuran - 131^I do wstrzykiwań

A sodium iodohippurate (131i) product containing natrii iodohippurati (131i) solutio iniectabilis, registered in Poland by Narodowe Centrum Badań Jądrowych. The same ATC class is registered in 2 of our 19 countries.

ATC V09CX02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedHipuran - 131^I do wstrzykiwańATCV09CX02REGISTER NO.PL-100048720PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Sodium iodohippurate (131i) is registered in 2 of 19 countries.

Countries holding a registration under ATC V09CX02 (sodium iodohippurate (131i)), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Sodium iodohippurate (131i) · ATC V09CX02

2 / 19 countries

  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Natrii iodohippurati (131I) solutio iniectabilis
Manufacturer
Narodowe Centrum Badań Jądrowych
Country
Poland (PL)
ATC code
V09CX02
ATC class
Sodium iodohippurate (131I)
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990327218

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sodium iodohippurate (131i) in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sodium iodohippurate (131i) products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dc608984-22e3-4f0e-9280-d209b174ee01
GET /v1/drugs/dc608984-22e3-4f0e-9280-d209b174ee01?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań",
  "source": "urpl",
  "strength": "3,7-74 MBq/ml",
  "packaging": "05909990327218 ¦ Lz ¦ 61594\n1 fiol.",
  "substance": "Natrii iodohippuras 131 J -",
  "common_name": "Natrii iodohippurati (131I) solutio iniectabilis",
  "pl_product_id": "100048720",
  "pozwolenie_nr": "03272",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about sodium iodohippurate (131i).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.